Home › Upcoming votes › Dare Bioscience, Inc.
The deadline as the proxy statement states it: “vote by 11:59 p.m. Eastern Time on November 9, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Dare Bioscience, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Approve potential future issuance of common stock upon exercise of warrants | Board | For | — |
| 2 | Approve adjournment of the special meeting Adjournment |
Board | For | — |
From Dare Bioscience, Inc.’s Form 8-K, filed July 9, 2025, for the meeting held June 12, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Gregory W. Matz, CPA | 93% | Elected |
| Elect Director: William H. Rastetter, Ph.D. | 94% | Elected |
| Elect Director: Robin J. Steele, J.D., L.L.M. | 95% | Elected |
| Proposal 2: Our stockholders ratified the appointment of Haskell & White LLP as our independent registered public accounting firm for the fi | 98% | Approved |
| Proposal 3: Our stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Stat | 91% | Approved |
| Proposal 4: Our stockholders approved the 2022 Plan Amendment by the votes set forth below. | 87% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.